News | News By Subject | News by Disease News By Date | Search News

Respiratory tract infections News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Bay Area's Raptor (RPTP) Beefs Up Portfolio With $453 Million Deal for Quinsair     8/21/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
AstraZeneca PLC (AZN) Touts Success In 2 Phase 2 Studies     5/15/2014
Pharmacopeia, Inc. (PCOP) Receives Milestone Payment from GlaxoSmithKline (GSK) as a Result of Lead Compound Identification     6/4/2008
Silence Therapeutics plc Signs $400 Million siRNA Research & Development Collaboration With AstraZeneca PLC (AZN) to Develop Novel Respiratory Therapeutics     7/6/2007
Discovery Laboratories (DSCO) Updates Progress On Manufacturing Remediation And Surfaxin FDA Regulatory Matters     9/28/2006
Accentia Biopharmaceuticals Acquires Exclusive License For An Additional Late-Stage Respiratory Product     12/6/2005
NicOx SA (NCOX.F) And TOPIGEN Pharmaceuticals Inc. Sign Deal On Respiratory Drug     10/27/2005
FDA Accepts Discovery Laboratories (DSCO)' Complete Response To Approvable Letter For Surfaxin     10/21/2005
MedImmune, Inc. (MEDI) Amends U.S. Co-Promotion Agreement For Synagis(R) With Abbott Laboratories (ABT); MedImmune Plans To Hire 125     8/31/2005
Anthera Pharmaceuticals, Inc. Launches With A Proven Leadership Team And Significant Series A Funding     4/21/2005
Theravance, Inc. (THRX) Announces GlaxoSmithKline (GSK) License Of Third Respiratory Program; Up To $252 Million In Upfront And Milestone Payments     3/22/2005
FDA Approves Sepracor, Inc.'s (SEPR) XOPENEX HFA(TM) Metered-Dose Inhaler     3/14/2005
Rigel Pharmaceuticals, Inc. (RIGL) And Pfizer Inc. (PFE) Sign Collaborative Research And License Agreement For The Treatment Of Allergic Asthma And Other Respiratory Diseases     1/20/2005

News from Around the Web
Doctors Could Use Snot Instead Of Blood For Diagnostics--Why Don’t They? San Diego State University Reveals     11/18/2015
Ibuprofen No Good in Treating Colds or Sore Throats, University of Southampton Study     11/5/2013
Vitamin D May Prevent Serious Respiratory Disease in Newborns, University Medical Center and Collaborators Study     5/10/2011
UK's National Institute for Health and Clinical Excellence Urges Doctors to Cut Antibiotics     7/23/2008
Flu or Respiratory Infections Linked to Increased Heart Attacks and Strokes     12/6/2007
Steroid Medications Don't Work in Treating Lower Respiratory Infections in Children, University of Utah Study     7/26/2007
Infection Risk In Kids Living Near Landfills     9/8/2006
Novexel Begins Phase I Trial, Gathers In Milestone Payment     10/12/2005
New Childhood Virus Tied To Respiratory Infections     8/23/2005
Vitamin Pills Don't Prevent Infections In Elderly     8/5/2005
Scientists Identify SARS Receptor     7/11/2005
Inadvertent Use of Bicillin C-R To Treat Syphilis Infection - Los Angeles, California, 1999--2004     3/14/2005
Legionnaire's Germ Yields Genetic Code     9/24/2004
UK's Profile Therapeutics Inhaler Approved In U.S.     4/28/2004
Zinc Speeds Recovery From Pneumonia In Boys     4/1/2004

Press Releases
Curetis Completes Sample Enrollment In Unyvero FDA Trial In Lower Respiratory Tract Infections     6/29/2016
Therabron Announces New Study Aimed At The Creation Of Multiple Novel Isoforms Of The Company's Lead Product Candidate     3/2/2016
Regeneron (REGN) Reports Fourth Quarter And Full Year 2015 Financial And Operating Results     2/9/2016
Akorn, Inc. (AKN) Launches Buprenorphine/Naloxone Sublingual Tablets And Tobramycin Injection     1/19/2016
RPS Diagnostics Announces Canadian Approval Of Febridx Test To Help Rapidly Differentiate Viral From Bacterial Acute Respiratory Infection At The Point Of Care     1/6/2016
PrEP Biopharm Limited Closes GBP 21 Million Series A Financing     11/2/2015
TetraPhase Pharmaceuticals (TTPH) Release: FDA Grants QIDP Designation And Fast Track Status To TP-271     9/3/2015
Aradigm Corporation (ARDM) Announces Second Quarter 2015 Financial Results     8/13/2015
Novavax (NVAX) Announces Positive Top-Line Data From Phase 2 RSV F-Protein Vaccine Clinical Trial In Older Adults     8/11/2015
Curetis Initiates Next Phase Of Unyvero U.S. FDA Trial In Lower Respiratory Tract Infections     7/8/2015
Valeant Pharmaceuticals North America LLC Issues Voluntary Recall Of Virazole® (Ribavirin Powder For Solution) In The United States     12/31/2014
Hemispherx Biopharma (HEB) Announces New Publication With Potential Insight Into High Mortality Rate In Middle Eastern Respiratory Syndrome (MERS)     6/16/2014
Cerecor Inc. Announces Initiation of CLIN01-002-A     5/21/2012
Perrigo Company (PRGO) Receives Final FDA Approval for Store Brand Equivalent to Generic Version of Mucinex®     11/28/2011
Pulmatrix's PUR118 Demonstrates Potential to Reduce Acute Exacerbations of the Lung Associated with Progressive Respiratory Diseases, such as COPD, Asthma, CF, and Respiratory Infections     9/27/2011

//-->